KN
About
Kevin N. Heller is the Chief Medical Officer of Tallac Therapeutics. He previously worked at Jasper Therapeutics as an Executive Vice President Research and Development. Kevin N. Heller attended Yale University.
Position in the VCSift Database
- • 37 investors hold the Chief Medical Officer role in VCSift. Kevin N. Heller is one of them.
- • 1,381 investors are based in Washington, District of Columbia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Washington, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Kevin
Search Investors